Labor, Michelle .

HRN: 28-62-76  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/28/2026
METRONIDAZOLE 500MG (TAB)
02/28/2026
03/06/2026
ORAL
500mg
TID X 7days
Thickly Msaf
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: